Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study

M. Manoharan, R. Ayyathurai, A. M. Nieder, M. S. Soloway

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84%) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (±1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (±6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalProstate Cancer and Prostatic Diseases
Issue number3
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research


Dive into the research topics of 'Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study'. Together they form a unique fingerprint.

Cite this